Invention Application
- Patent Title: TRICYCLIC HETEROARYL COMPOUNDS USEFUL AS IRAK4 INHIBITORS
-
Application No.: US17792837Application Date: 2021-02-02
-
Publication No.: US20230114683A1Publication Date: 2023-04-13
- Inventor: Saleem Ahmad , Lidet A. Negash
- Applicant: BRISTOL-MYERS SQUIBB COMPANY
- Applicant Address: US NJ Princeton
- Assignee: BRISTOL-MYERS SQUIBB COMPANY
- Current Assignee: BRISTOL-MYERS SQUIBB COMPANY
- Current Assignee Address: US NJ Princeton
- International Application: PCT/US2021/016126 WO 20210202
- Main IPC: C07D471/04
- IPC: C07D471/04 ; C07D471/14
Abstract:
Disclosed are compounds of Formulas (I) or (II) or a salt thereof, wherein X, R1, R2, R3, and n are defined herein. Also disclosed are methods of using such compounds as modulators of IRAK4, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating, preventing, or slowing inflammatory and autoimmune diseases, or in the treatment of cancer.
Public/Granted literature
- US2310381A Treatment of ferrous bearing metals Public/Granted day:1943-02-09
Information query
